Literature DB >> 23254631

Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis.

Nicole S Schmid1, Kirsten I Taylor, Nancy S Foldi, Manfred Berres, Andreas U Monsch.   

Abstract

We investigated the earliest neuropsychological changes in Alzheimer's disease (AD) by comparing the baseline performance of 29 individuals who subsequently developed AD within an average of 7.91 ± 2.70 years with 29 pairwise-matched individuals who remained cognitively healthy (NC). We hypothesized that subtle, qualitative changes in cognition precede clinical AD by several years, and therefore examined subjective as well as standard quantitative measures of cognition, in addition to subjective estimates of mood and medical status. Participants were selected from the 825 members of the longitudinal BASEL study (BAsel Study on the ELderly), all of whom had been ApoE-genotyped and received comprehensive bi-annual neuropsychological assessments. Within 13 years, 29 were diagnosed with probable AD. Each individual who progressed to AD (AD-P) was pairwise matched to a NC participant based on age, education, demographic status, observation period, and, importantly, ApoE genotype. A regression analysis using the lasso technique identified which of 115 neuropsychological variables best discriminated baseline NC from baseline AD-P performance. This analysis yielded eleven neuropsychological variables that optimally discriminated the two groups (correct classification rate: 60.4%): 1) Intrusions and 2) response bias in verbal learning and memory tasks; 3) delayed figure recall; 4-6) three Wechsler Adult Intelligence Scale (WAIS) Block Design subtest variables; 7-8) number of errors and repetitions on letter fluency; and 9-11) self-report of memory problems, a feeling of sadness, and cardiac problems. These results suggest that the preclinical neuropsychological cascade to AD includes subtle but identifiable qualitative impairments in verbal and visual memory, visuospatial processing, error control, and subjective neuropsychological complaints.

Entities:  

Mesh:

Year:  2013        PMID: 23254631     DOI: 10.3233/JAD-121234

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

Review 1.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

2.  Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.

Authors:  Kevin Duff; Norman L Foster; John M Hoffman
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

3.  Response bias and response monitoring: Evidence from healthy older adults and patients with mild Alzheimer's disease.

Authors:  Rebecca G Deason; Michelle J Tat; Sean Flannery; Prabhakar S Mithal; Erin P Hussey; Eileen T Crehan; Brandon A Ally; Andrew E Budson
Journal:  Brain Cogn       Date:  2017-09-17       Impact factor: 2.310

4.  Single neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.

Authors:  Mili Parikh; Linda S Hynan; Myron F Weiner; Laura Lacritz; Wendy Ringe; C Munro Cullum
Journal:  Clin Neuropsychol       Date:  2014-08-18       Impact factor: 3.535

5.  False memories in patients with mild cognitive impairment and mild Alzheimer's disease dementia: Can cognitive strategies help?

Authors:  Christopher Malone; Rebecca G Deason; Rocco Palumbo; Nadine Heyworth; Michelle Tat; Andrew E Budson
Journal:  J Clin Exp Neuropsychol       Date:  2018-09-04       Impact factor: 2.475

6.  Visual memory tests enhance the identification of amnestic MCI cases at greater risk of Alzheimer's disease.

Authors:  Javier Oltra-Cucarella; Miriam Sánchez-SanSegundo; Darren M Lipnicki; John D Crawford; Richard B Lipton; Mindy J Katz; Andrea R Zammit; Nikolaos Scarmeas; Efthimios Dardiotis; Mary H Kosmidis; Antonio Guaita; Roberta Vaccaro; Ki Woong Kim; Ji Won Han; Nicole A Kochan; Henry Brodaty; José A Pérez-Vicente; Luis Cabello-Rodríguez; Perminder S Sachdev; Rosario Ferrer-Cascales
Journal:  Int Psychogeriatr       Date:  2018-10-25       Impact factor: 3.878

7.  A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.

Authors:  Rosie E Curiel; Elizabeth Crocco; Marian Rosado; Ranjan Duara; Maria T Greig; Arlene Raffo; David A Loewenstein
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

8.  Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease.

Authors:  Ian M McDonough; Gérard N Bischof; Kristen M Kennedy; Karen M Rodrigue; Michelle E Farrell; Denise C Park
Journal:  Neurobiol Aging       Date:  2016-06-25       Impact factor: 4.673

9.  Linear and nonlinear relationships between cognitive subdomains of ability discrepancy and Alzheimer's disease biomarkers.

Authors:  Ian M McDonough; Taylor E Popp
Journal:  Neuropsychology       Date:  2019-12-02       Impact factor: 3.295

10.  Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.

Authors:  Ganesh M Babulal; Nupur Ghoshal; Denise Head; Elizabeth K Vernon; David M Holtzman; Tammie L S Benzinger; Anne M Fagan; John C Morris; Catherine M Roe
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-19       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.